Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Biotech Isendahl AB
AB
Active
Org 5594070731
Dag Hammarskjölds Väg 3 E, 224 64
Lund
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2022
1 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Biotech Isendahl AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2023
1M
2024
1M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2023
2024
2025
Revenue
757
925
864
Staff expenses
−687
−861
−779
EBITDA
44
29
43
Depreciation & amort.
—
—
—
EBIT
44
29
43
Net financials
0
1
0
Profit before tax
45
30
43
Tax
−10
−6
−9
Net profit
35
24
34
Balance sheet
SEK thousands
Item
2023
2024
2025
Total assets
356
326
308
Equity
60
84
119
Long-term debt
—
—
—
Short-term debt
296
242
189
Total debt
296
242
189
Financial ratios
5-year trend
EBITDA margin
5.0%
This company
15.8%
Market median
-68% vs market
2023
2025
Equity ratio
38.6%
This company
38.2%
Market median
+1% vs market
2023
2025
Return on equity
29.0%
This company
18.4%
Market median
+58% vs market
2023
2025
Net profit margin
4.0%
This company
8.1%
Market median
-51% vs market
2023
2025
Asset turnover
2.81×
This company
1.12×
Market median
+151% vs market
2023
2025
Debt / equity
1.59×
This company
0.62×
Market median
-156% vs market
2023
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-10-01 – 2025-09-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-10-01 – 2024-09-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-11-21 – 2023-09-30
View
PDF
More on Biotech Isendahl AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
